Patients were randomised ( by an independent nurse , in 1:1 ratio , with permuted block size of four and six , using a centralised , secure web-based randomisation service ) to receive haloperidol 2.5 mg or 0.9 % saline placebo intravenously every 8 h , irrespective of coma or delirium status .